We are getting excited to once again exhibit at the ISPOR Annual Meeting to be held in Philadelphia, PA, May 17-20, 2026.
Find us at Booth # 511
- Monday 9:30 AM-7:00 PM
- Tuesday 9:30 AM-7:00 PM
- Wednesday 8:30 AM-11:30 AM
Meet the team and check out our poster presentations:
Monday, May 18
PODIUM PRESENTATION, 10:30-11:30 AM
- Real-world effectiveness of anti-obesity pharmacotherapy in Medicare: Integrated 100% Fee-For-Service claims and EMR analysis of BMI reduction and cardiovascular outcomes
ONCOLOGY POSTER TOUR, 11:30 AM-12:15 PM
- Targeted therapy, immunotherapy, and molecular testing in advanced solid tumors: A 2021–2025 Medicare analysis (PT6)
Poster Session 1 Discussion: 12:30-1:30 PM
-
Early identification of postpartum depression risk using artificial intelligence (MSR7)
-
Real-world impact of anti-amyloid therapy in Alzheimer’s disease: An integrated analysis of 100% Medicare FFS claims linked with laboratory, electronic medical records, and patient-reported outcomes measures (CO21)
Poster Session 2 Discussion: 6-7 PM
- Modeling rare events in health intervention: An application from the Department of War dataset (MSR69)
Tuesday, May 19
Poster Session 3 Discussion: 12:30-1:30 PM
-
Real-world safety and outcomes of bispecific antibodies in older adults (CO106)
-
Real-world impact of modern obesity pharmacotherapy on liver outcomes in Medicare-Enhanced Lab and Demographics data: 2021–2025 (CO88)
-
Projected impact of personalized mRNA neoantigen cancer vaccines in Medicare: A scenario analysis using trial efficacy and linked data population estimates (EPH113)
-
Healthcare resource use in rare disease clinical trials: A systematic review (EE277) TOP 5% FINALIST
Poster Session 4 Discussion: 6-7 PM
-
Laboratory markers and short-term outcomes in respiratory syncytial virus among older adults: Medicare-Enhanced and Laboratory Data analysis 2021–2025 (CO153)
-
Real-world multiple myeloma treatment responses: Evaluation of frontline regimens in MELD TM linked Medicare, laboratory and electronic medical records (CO144)
-
Prevalence and incidence of obesity and budget impact of the MOVE! Weight Management Program in US veterans (EPH143)
-
Real-world perioperative immunotherapy and cellular therapy in older adults with solid tumors: A 2021–2025 Medicare-EMR linked analysis (CO143) TOP 5% FINALIST
Wednesday, May 20
Poster Session 5 Discussion: 9-10 AM
-
Comparative risk of suicidal ideation and self-harm among patients with major depressive disorder treated with brexpiprazole vs other oral atypical antipsychotics: A propensity score–matched cohort analysis (CO175)
-
Inflation Reduction Act “pill penalty” and small-molecule innovation: Signals from investment, pipelines, and post-approval research (HPR139)
-
Timing of serious adverse events following mifepristone abortion in US commercial and Medicaid populations (CO189)
-
Treatment patterns and gaps in resectable mucosal melanoma care for Medicare beneficiaries in the United States (CO186)
Learn more about ISPOR.
Find more CDA presentations and publications here.
